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The kinetics of ligand gated ion channels are tuned
to permit diverse roles in cellular signaling. To follow
high-frequency excitatory synaptic input, postsyn-
aptic AMPA-type glutamate receptors must recover
rapidly from desensitization. Chimeras between
AMPA and the related kainate receptors demon-
strate that the ligand binding domains alone control
the lifetime of the desensitized state. Mutation of
nonconserved amino acids in the lower lobe (domain
2) of the ligand binding domain conferred slow
recovery from desensitization on AMPA receptors,
and fast recovery on kainate receptors. Single-
channel recordings and a correlation between the
rate of deactivation and the rate of recovery across
panels of mutant receptors revealed that domain 2
also controls ion channel gating. Our results demon-
strate that the same mechanism that ensures fast
recovery also sharpens the response of AMPA chan-
nels to synaptically released glutamate.
INTRODUCTION
Glutamate receptors mediate fast excitatory transmission in
the brain and are candidate substrates for storage of memories
through plastic changes in their synaptic distributions. The
AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic
acid) subtype of glutamate receptors can follow synaptic activity
in the kilohertz range (Taschenberger and von Gersdorff, 2000)
because they allow glutamate to unbind rapidly and can recover
from desensitization quickly (Colquhoun et al., 1992). In contrast,
both recombinant and native kainate receptors recover from
desensitization about 100-fold more slowly (Bowie and Lange,
2002; Paternain et al., 1998). Desensitization occurs at synapses
even during a single postsynaptic response (Otis et al., 1996),
although this may be masked by fast recovery and lateral
mobility of receptors (Frischknecht et al., 2009). Short-term
depression due to desensitization facilitates neuronal com-
putation (Rothman et al., 2009) and normal desensitization of
AMPA receptors also appears critical for brain development
(Christie et al., 2010).AMPA and kainate receptors have the same overall structure
(Sobolevsky et al., 2009; Das et al., 2010). A global axis of 2-
fold symmetry, perpendicular to the membrane plane, defines
dimers of ligand binding domains (LBDs). AMPA and kainate
receptors desensitize when this dimer relaxes (Chaudhry et al.,
2009a; Sun et al., 2002; Armstrong et al., 2006), but molecular
determinants of the lifetime of the resulting desensitized state
are unknown. Each ligand binding domain is a clamshell which
closes upon glutamate binding. Some hydrogen bonds that
form between the jaws of the binding domain in GluK2 following
glutamate binding are absent in AMPA receptors (Weston et al.,
2006b). However, mutant kainate receptors that lack these inter-
actions still recover slowly from desensitization. Introducing
similar interactions to AMPA receptors slows deactivation and
decreases glutamate potency sharply, but does not slow
recovery profoundly. Hence, interactions distinct from those at
the jaws of the ligand binding domain must control the rate of
recovery from the desensitized state.
Studies of chimeric glutamate receptors have elucidated
glutamate receptor gating (Gielen et al., 2009; Rosenmund
et al., 1998), desensitization (Stern-Bach et al., 1998), and
assembly (Ayalon et al., 2005). In a landmark study, chimeras
between GluA3 and GluK2 defined the ligand binding domain
(Stern-Bach et al., 1994), but kinetic comparisons were impos-
sible because some chimeras were nonfunctional. We con-
structed fully functional reciprocal chimeras of AMPA and
kainate receptors, examined their biophysical properties for
the first time and employed kinetic modeling to understand their
behavior. Subsequently, we identified residues that determine
the lifetime of the desensitized state in AMPA and kainate recep-
tors. Our mutant screens reveal a surprising coregulation of
channel gating behavior by distributed sites within the lower
jaw of the LBD.
RESULTS
Chimeras of AMPA and Kainate Receptors with
Exchanged Recovery Rates
The pore domains of AMPA and kainate receptors are similar,
and removing the amino terminal domain (ATD) does not alter
recovery (Pasternack et al., 2002; Plested and Mayer, 2007).
For these reasons, and because the LBDs rotate upon entry
to desensitization (Armstrong et al., 2006), we hypothesized
that interactions determining the rate of recovery fromNeuron 74, 845–857, June 7, 2012 ª2012 Elsevier Inc. 845
Figure 1. The Ligand Binding Domain Determines Glutamate
Receptor Recovery
(A) The domain organization of wild-type AMPA (GluA2, red) and kainate
(GluK2, blue) receptor subunits and chimeras. The topology of B6P2 and B2P6
chimeras is the same as wild-type channels, with the S1 and S2 segments
combining to form the extracellular ligand binding domain (LBD). An orange
bar represents the membrane. ATD: amino terminal domain; M1-M4: trans-
membrane segments.
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We began our search for elements that control recovery from
desensitization by constructing chimeric receptors in which
we swapped the ligand binding cores between GluA2 (AMPA)
and GluK2 (Kainate) receptors (Figure 1A). These subtypes
are present in many native receptor complexes (Sans et al.,
2003; Breustedt and Schmitz, 2004) and form recombinant
homomeric receptors that differ about 100-fold in recovery
rate. We called the chimeras B2P6, for the LBD from GluA2
with the pore and ATD of GluK2 (GluR6) and B6P2, for the
LBD from GluK2 (GluR6) with the pore and ATD of GluA2.
Startlingly, in the B2P6 chimera, the presence of the GluA2
LBD conferred extremely fast recovery from desensitization,
with a recovery rate of 63 ± 6 s1 (Figures 1B and 1C, Hodg-
kin-Huxley-type-fit slope = 2, n = 7), even faster than that of
wild-type GluA2 (47 ± 6 s1, n = 10). This rate of recovery is
more than 100-fold quicker than that of GluK2 (0.47 ± 0.03 s1,
monoexponential fit, n = 14). The inverse chimera, B6P2,
including the GluK2 LBD, recovered slowly from desensitization
(krec = 0.39 ± 0.01 s
1, monoexponential fit, n = 10 patches),
also 100-fold slower than wild-type GluA2. To compare fairly
between recovery relations with different slopes, we also
calculated the time of 50% recovery (t50) for chimeric and wild-
type receptors (Figure 1E), which also indicated a complete
exchange of the lifetime of the desensitized state with the ligand
binding domain. These results show that no part of the kainate
receptor outside the binding site contributes to the very slow
recovery from desensitization observed in heterologously
expressed wild-type GluK2 channels, and in native kainate
receptors (Bowie and Lange, 2002; DeVries and Schwartz,
1999; Paternain et al., 1998). Likewise, the fast recovery of
recombinant and native AMPA receptors (Zhang et al., 2006;
Colquhoun et al., 1992) must be explained entirely by determi-
nants within the LBD.
Transplanted LBDs Behave as in Wild-Type Donors
The isolated LBDs of AMPA and kainate receptors are autono-
mous modules that recapitulate the properties of LBDs in
full-length receptors (Armstrong and Gouaux, 2000; Mayer,
2005). When activated by 10 mM glutamate, both the B2P6
and B6P2 chimeras exhibited fast activation and desensitization
similar to wild-type receptors (Figure S1A available online),
although the B2P6 chimera desensitized more slowly and less(B) Wild-type GluA2 receptors recover rapidly from desensitization (left panel,
red curve, Hodgkin-Huxley fit with slope 2, krec = 34 s
1). In contrast, wild-type
GluK2 receptors recover 2 orders of magnitude more slowly (right panel, blue
curve, monoexponential fit, krec = 0.8 s
1).
(C) The B2P6 chimera recovers as rapidly from desensitization as wild-type
GluA2 (red curve, Hodgkin-Huxley fit with slope 2, krec = 27 s
1), whereas the
inverse chimera, B6P2, has indistinguishable recovery from wild-type GluK2
(blue fitted curve, monoexponential fit krec = 0.5 s
1).
(D) Hodgkin-Huxley type functions fitted to pooled data. For B2P6, krec = 63 ±
6 s1 for B2P6 (slope = 2, n = 7) and krec = 0.39 ± 0.01 s
1 for B6P2 (slope = 1,
n = 10). Dotted and dashed lines show recovery curves for wild-type GluA2
(slope = 2, n = 10) and wild-type GluK2 (slope = 1, n = 14), respectively. Error
bars represent standard deviation of the mean (SDM).
(E) Bar plot summarizing exchange of half-recovery times (t50) on a log scale.
See also Figures S1 and S2 for further characterization of chimeric receptors.
Table 1. Kinetic Properties of Wild-Type and Mutant AMPA and Kainate Receptors
krec (s
1) Slope t50 (ms) kdes (s
1) Iss / Ipeak kdeact (s
1)
WT A2 47 ± 6 (10) 2 26 ± 3 98 ± 5 (25) 2.8 ± 0.4% 1,300 ± 130 (9)
WT K2 0.47 ± 0.03 (14) 1 1,500 ± 100 150 ± 10 (15) 0.9 ± 0.3% 330 ± 20 (17)
B2P6 63 ± 6 (7) 2 20 ± 2 81 ± 4 (15) 21 ± 1% 350 ± 40 (8)
B6P2 0.39 ± 0.01 (10) 1 1,800 ± 50 293 ± 15 (18) 0.16 ± 0.03% 580 ± 140 (3)
A2 R675S 81 ± 12 (5) 2 15 ± 2 108 ± 9 (5) 3.9 ± 2.5% 1,200 ± 200 (5)
A2 M708T 68 ± 9 (5) 2 18 ± 2 138 ± 15 (5) 2.8 ± 1.4% 1,400 ± 250 (5)
A2 E713T 16 ± 3 (6) 2 75 ± 13 128 ± 12 (6) 1.6 ± 0.6% 510 ± 30 (5)
A2 K761M 72 ± 9 (9) 2 17 ± 2 133 ± 10 (9) 2.6 ± 0.5% 2,100 ± 300 (9)
A2 Y768R 15 ± 1 (10) 1 47 ± 5 89 ± 7 (10) 8.6 ± 2.3% 470 ± 50 (6)
A2 K770N 27 ± 3 (6) 2 46 ± 5 110 ± 20 (6) 4.3 ± 1.2% 700 ± 200 (6)
A2 TR (E713T Y768R) 1.1 ± 0.2 (10) 1 640 ± 110 129 ± 8 (14) 1.7 ± 0.5% 189 ± 17 (7)
A2 S652D TR 0.4 ± 0.1 (6) 1 2,900 ± 200 110 ± 30 (7) 3.9 ± 3.3% 197 ± 3 (2)
K2 E650A 0.7 ± 0.1 (5) 1 1,000 ± 100 240 ± 20 (5) 0.2 ± 0.1% 430 ± 50 (5)
K2 S679R 1.3 ± 0.1 (4) 1 500 ± 100 207 ± 9 (3) 0.5 ± 0.3% 400 ± 60 (5)
K2 M706L 2.7 ± 0.3 (9) 1 250 ± 30 200 ± 30 (14) 0.8 ± 0.1% 2,200 ± 200 (12)
K2 T715E 0.54 ± 0.06 (7) 1 1,300 ± 100 156 ± 10 (5) 0.9 ± 0.5% 500 ± 100 (5)
K2 R769Y 0.41 ± 0.06 (5) 1 1,700 ± 200 150 ± 10 (6) 0.7 ± 0.4% 290 ± 30 (6)
K2 —EY 0.24 ± 0.01 (6) 1 2,900 ± 100 160 ± 20 (6) 1.0 ± 0.3% 240 ± 30 (3)
K2 –LE- 3.5 ± 0.5 (6) 1 200 ± 30 180 ± 20 (10) 1.1 ± 0.2% 1,300 ± 150 (9)
K2 –L-Y 2.9 ± 0.5 (4) 1 200 ± 0 200 ± 20 (6) 0.8 ± 0.1% 800 ± 300 (5)
K2 –LEY 1.60 ± 0.1 (5) 1 430 ± 20 210 ± 10 (6) 1.8 ± 0.6% 1,200 ± 200 (5)
K2 -RLE- 4.6 ± 0.4 (11) 1 150 ± 10 180 ± 20 (10) 2.6 ± 0.5% 1,500 ± 100 (15)
K2 ARLE- 8.6 ± 0.7 (6) 1 80 ± 10 190 ± 40 (6) 2.6 ± 0.6% 1,500 ± 200 (6)
All recovery data were fitted with Hodgkin-Huxley-type relations with the slope fixed to either 1 or 2, as indicated. The terms krec, kdes, kdeact are rates of
recovery from desensitization, desensitization, and deactivation, respectively; t50 is the half-time of recovery; Iss/Ipeak is the steady state current ex-
pressed as a percentage of the peak. Values are shown as mean ± SD of the mean. The five individual GluK2 point mutants listed here were combined
to give double, triple, and quadruple mutants as indicated (in sequential order; dashes represent wild-type residues).
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ing the binding domains might produce receptors with strongly
shifted affinities for glutamate, which would be expected to alter
the lifetime of the desensitized state in wild-type and mutant
GluRs (Zhang et al., 2006; Weston et al., 2006b). To check this,
we determined concentration response relations for peak
currents following fast application of glutamate (Figure S1B).
Wild-type GluA2 had glutamate EC50 of 1,100 ± 140 mM (n = 6
patches). Glutamate was about 9-fold more potent at activating
wild-type GluK2 receptors (EC50 = 130 ± 30 mM; n = 4, p = 1.6%
versusWT A2; Student’s t test). For the B2P6 chimera, the gluta-
mate EC50 was 470 ± 80 mM (n = 6; p = 30% versus WT K2 and
15% versus WT A2) and for the B6P2 chimera, it was 800 ±
150 mM (n = 4; p = 20% versus WT A2 and 8.8% versus WT
K2). Thus glutamate activated both chimeras with a similar
potency to the wild-type donors, consistent with limited differ-
ences in affinity for nondesensitized states.
AMPA is barely active at homomeric kainate receptors
(Egebjerg et al., 1991), because it is sterically excluded from
the GluK2 binding site (Mayer, 2005). Consistent with these
observations, and previously published radioligand binding
studies (Stern-Bach et al., 1994), AMPA (1 mM) activated the
B2P6 chimera (61% ± 7% of response to 10 mM glutamate in
the same patch, n = 7 patches) and wild-type GluA2, but failedto evoke a response in the B6P2 chimera (Figure S1C). Kainate
only partially closes the LBD of GluA2 upon binding (Armstrong
and Gouaux, 2000) and is a very weak partial agonist of the
GluA2 channel (Plested and Mayer, 2009), but activates kainate
receptors efficaciously. Kainate (1 mM) activated a rapidly
desensitizing response in the B6P2 chimera that was about
one-third the amplitude of that generated by 10 mM glutamate
(kdes = 240 ± 70 s
1, peak 28% ± 11%, n = 5 patches), similar
to the response of GluK2 wild-type receptors. The response of
the B2P6 chimera to 1 mM kainate was small (4% ± 1% of the
glutamate peak current, n = 4 patches). Such closely matching
preferences for glutamatergic ligands strongly argues that the
LBDs were transferred intact.
We used selective allosteric modulators to check the integrity
of the active dimer interface in the chimeric receptors. Cyclo-
thiazide (CTZ; 100 mM) increased the steady state current in
the presence of 10 mM glutamate about 4-fold, to 82% ± 2%
of the peak (n = 5 patches) for the B2P6 chimera (Figure S1D).
Cyclothiazide blocks desensitization in wild-type GluA2 by 96%
(Sun et al., 2002), but a point mutation in the CTZ binding site
abolishes modulation (Partin et al., 1995), so this inhibition of
desensitization is consistent with an intact dimer-interface
binding site for CTZ. Monovalent ions control the kinetics of
GluK2 but do not affect GluA2 (Plested et al., 2008). IonNeuron 74, 845–857, June 7, 2012 ª2012 Elsevier Inc. 847
Figure 2. Kinetic Modeling of Chimera Kinetics
(A) Simplified model of glutamate receptor gating. For the simulation shown in
(B)–(E), the lifetime of the deep desensitized state (AD2) was varied by
systematically changing d2– (red arrow).
(B) Simulated recovery from desensitization profiles for a range of values of
d2–. Traces are colored according to values of d2– indicated as in the upper
panel.
(C) Simulated currents in response to 10 mM glutamate. Inset shows that all
values of d2– produced responses with the same peak open probability. As
d2– becomes fast, a steady-state component develops, as for the B2P6
chimera.
(D) One thousand fold variation in d2– does not shift the peak open-probability-
concentration relation. Curves for the entire range of values of d2– were
indistinguishable, and glutamate EC50 was about 400 mM.
(E) Summary plot shows glutamate potency (EC50, filled circles) and recovery
rate (krec) against the value of d2– in each simulation.
(F) Varying the unbinding rates from the desensitized state (kd–, red) and the
resting state (k–, green, to enforcemicroscopic reversibility) gave rise to atmost
a 10-fold shift in recovery rate, but shifted glutamate potency by more than 2
orders ofmagnitude (blue circles). Simulationswere doneon twobackgrounds:
either low (0.5 s1, open circles) or high values of d2– (100 s1, filled circles).
(G) Varying the exit rate from the first desensitized state (red) could not
reproduce fast recovery on a background of slow value of d2– (open circles) or
slow recovery on a fast value of d2– (filled circles). The unbinding rate from the
desensitized state (kd–, green) was altered to imposemicroscopic reversibility.
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binding domain (Figure S1E). The B6P2 chimera was strongly
inhibited upon substitution of cations (CsCl peak current
0.3% ± 0.2% of that in NaCl, n = 5 patches), and anions
(NaNO3 peak current 36% ± 15%, n = 4 patches), similar to
GluK2 wild-type channels (CsCl, 7%; NO3, 75%; Plested and
Mayer, 2007). Small disruptions of the ion binding sites gener-
ally invert sensitivity, so the active dimer arrangement in B6P2
channels must be similar to that in GluK2. The B2P6 chimera
was completely insensitive to ion exchanges (peak currents,
relative to NaCl: 94% ± 1% for CsCl; 95% ± 5%, NaNO3, n =
3, not shown).
Glutamate (10 mM) activated a large steady state current at
the B2P6 chimera (21% ± 1% of peak, n = 15 patches), reminis-
cent of the Willardiine series of partial agonists (Jin et al., 2003).
To check that glutamate remains a full agonist at the B2P6
chimera, we estimated open probability using noise analysis
(Figures S2A–S2D). Wild-type GluA2 receptors have a high
peak open probability (77% ± 7%, n = 5 patches), and the
peak open probability of the B2P6 chimera was not significantly
different (65 ± 5%, n = 5 patches; p > 0.05, randomization test).
Weighted single-channel conductance was also similar (WT A2:
18 ± 3 pS; B2P6: 16 ± 1 pS). Additionally, we checked if quisqua-
late, which activates a larger current than glutamate in GluA2
mutants where domain closure is hindered (Robert et al.,
2005), could activate bigger responses than glutamate at the
B2P6 construct (Figures S2E and S2F). Currents activated by
quisqualate (2 mM) and glutamate (10 mM) were similar in
amplitude (Quis. peak current: 92% ± 8% of that evoked by
10 mM glutamate, n = 5 patches), suggesting that domain
closure in the B2P6 channel is normal. These results exclude
spurious partial agonism as an explanation for fast recovery,
and suggest that the large steady state current in the B2P6
chimera is due to recovery that is even faster than wild-type
GluA2.
Kinetic Simulations of Chimeric Receptors
Our recordings of the B2P6 and B6P2 chimeras displayed
striking features that we reasoned could constrain parameters
in simulations of receptor kinetics and thereby provide insight
to the molecular mechanisms determining recovery from desen-
sitization. Our aim was to identify if individual kinetic transitions
could explain the observed behavior and, by comparing with
existing biophysical studies (Robert et al., 2005; Zhang et al.,
2008), pinpoint the region of the LBD most likely to control
recovery. Using a simplified model of GluR activation (see Fig-
ure 2A and Supplemental Experimental Procedures), we tried
three scenarios to account for changes in recovery rate. First,
we varied the lifetime of a deep desensitized state (AD2), from
which agonist dissociation was very slow. Second, alterations
in the bound lifetime of glutamate might change recovery, and
we simulated this on two backgrounds, with initially slow and
fast recovery, respectively. Finally, we tested the hypothesis
that the equilibrium between resting (AR) and desensitized
states (AD) differs between AMPA and kainate receptors.
The rate of recovery from desensitization was sensitive to rate
changes in each case. Strikingly, changing the rate of exit from
the state AD2 (d2–) caused a uniform shift in the recovery rate
Neuron
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between GluA2 and GluK2, and our chimeric receptors (Fig-
ure 2B). The variation in d2– was the only modification that
accounted well for all our observations, including the develop-
ment of a large steady state current in the presence of 10 mM
glutamate for fast recovering channels (B2P6; compare Fig-
ure 2C and Figure 1C). Similarly to our observations for chimeric
receptors, the peak current-concentration relation was not
changed by variation in the exit rate from AD2 (Figure 2D). In
contrast, reducing bound lifetime on the background of slow
recovery (by changing the rates k– and kd–) could not produce
the fast recovery of wild-type GluA2 and B2P6. Although slower
recovery is possible by slowing dissociation on a fast recovering
background, this is accompanied by major shifts and distortions
of the concentration response relation (Figure 2F). This scenario
reproduced well the findings of previous reports where muta-
tions at the jaws of the LBDs alter the stability or lifetime of all
glutamate bound states (Robert et al., 2005; Weston et al.,
2006b). However, apparent affinity was altered little in our
chimeras, ruling out changes in resting state affinity as the sole
explanation for the physiological difference between AMPA
and kainate receptors, and between our chimeras. The similar
rate of entry to desensitization for AMPA and kainate receptors,
and similar peak open probability, rules out significant changes
in the transition AR – AD, but variation in the reverse transition
(d1–) could conceivably produce different recovery rates –
perhaps corresponding to different re-association kinetics of
the active LBD dimers. We repeated the simulations, varying
the rate of exit from the AD state, again on two backgrounds,
slow and fast exit from the AD2 state (Figure 2G). These simula-
tions failed to give a wide range of recovery rates. Rather, the
simulated currents strongly resembled the results of manipula-
tions that stabilize the D1 dimer interface (data not shown). The
variation in exit fromAD on a background of fast recovery resem-
bled the effect of the L483Ymutant or allosteric modulators such
as cyclothiazide (Sun et al., 2002). The same manipulation on
a slow background reproduced the effects of stabilizing the
GluK2 D1 dimer interface with mutations (Chaudhry et al.,
2009b).
More complex covariations of multiple rate constants (or
more realistic activation mechanisms) could potentially also
recreate our observations. However, the kinetic behavior caused
by variation in the lifetime of a deep desensitized state is quite
distinct from the effects reported in previously published
studies (see above). This distinction drew us to investigate
differences between GluA2 and GluK2, located away from
previously described sites that could differentially stabilize
a glutamate-bound, deep desensitized state.
Residues that Control the Lifetime of the Desensitized
State in AMPA Receptors
The ligand binding domains of AMPA and kainate receptors are
bilobed clamshell structures, comprising 250 amino acids of
highly conserved sequence (65% identity between GluA2 and
GluK2). Mutations in the upper lobe (D1) that do not involve
ligand contacts can alter desensitization entry rates, but have
minimal effects on recovery from desensitization (Horning and
Mayer, 2004; Stern-Bach et al., 1998). Likewise, intrasubunitinteractions at the clamshell jaws of the LBDs alter both recovery
and potency (Weston et al., 2006b; Robert et al., 2005). Because
rates of entry to desensitization and the potency of glutamate
to activate the receptor are similar in our chimeric receptors,
these regions do not determine the large difference in desensi-
tized lifetime between GluA2 and GluK2. We therefore turned
our attention to residues within the lower lobe (D2) that do not
make contacts with D1. We formed a panel of 16 mutants in
GluA2 (Figure S3), substituting the corresponding residue or
sequence from GluK2, and screened these for slowed recovery
from desensitization.
Fast desensitizing glutamate-activated currents were ob-
tained from 15 of the 16 mutants (Table 1 and Table S1), but
most (11) failed to slow the rate of recovery from desensitization
more than 2-fold, relative to wild-type GluA2. Some mutations
accelerated recovery. Two exchanges near to the base of the
LBD provoked recovery kinetics distinct from wild-type (Figures
3A and 3B). A mutation at the base of helix I, E713T, slowed
recovery about 3-fold compared to wild-type GluA2 (krec =
16 ± 3 s1; n = 6, Hodgkin-Huxley fit with slope 2). The Y768R
mutation, in helix K, made recovery monoexponential (as in
GluK2), with krec = 15 ± 1 s
1 (n = 10 patches). When these
two mutations were combined (GluA2 E713T Y768R; hereafter
TR) the slowing of recovery was supra-additive, with krec =
1.1 ± 0.2 s1 (n = 10 patches, Figures 3C and 3D). This rate is
more than 40-fold slower than wild-type GluA2. Including the
mutation S652D in the jaws of the LBD, to increase glutamate
affinity (Weston et al., 2006b), produced a poorly expressed
receptor (GluA2 DTR) that had even slower recovery from
desensitization than GluK2 wild-type (GluA2 DTR krec = 0.4 ±
0.1 s1, n = 6 patches) (Figure 3E). Consistent with the close
physical apposition of E713 and Y768 (see Figure 3F and
Discussion), mutant cycle analysis suggested a degree of ener-
getic coupling between these two residues for recovery from
desensitization (DDG = 1.6 ± 0.4 kT; Figure S4).
In wild-type receptors and our chimeras, despite large shifts in
recovery rate, EC50 values are similar (Figure S1B).Wemeasured
peak currents for the GluA2 TR double mutant activated by
concentration jumps of glutamate, largely avoiding desensitiza-
tion (Figure 4A). The glutamate EC50 was 230 ± 20 mM (n = 5
patches), similar to wild-type GluK2 channels, confirming that
slowing of recovery is not due to an inordinate increase in gluta-
mate potency. Glutamate activated the GluA2 Y768R single
mutant with EC50 = 640 ± 90 mM (n = 5, data not shown), so it
is plausible that the other mutants in our panel are activated by
glutamate with a potency similar to wild-type GluA2.
If glutamate binds more tightly to the desensitized state,
steady-state desensitization should occur at lower glutamate
concentrations. We measured the IC50 for desensitization by
glutamate using concentration jumps, with pre-exposure to
a range of glutamate concentrations (see Experimental Proce-
dures). For GluA2, as previously reported (Plested and Mayer,
2009), the half-inhibitory concentration (IC50) was more than
100-fold lower than the EC50 for activation (9 ± 1 mM; n = 3–11
patches per point; Figure 4B). Glutamate is even more potent
at inhibiting the slow recovering GluK2 receptor (IC50 = 700 ±
80 nM, n = 3–8 patches). Consistent with the much slower
recovery of the TR mutant, glutamate also blocked activationNeuron 74, 845–857, June 7, 2012 ª2012 Elsevier Inc. 849
Figure 3. Two Residues in the LBD Control AMPAR Recovery
(A) Overlay of six paired-pulse records with increasing intervals between pul-
ses. The GluA2 E713T mutant recovered from desensitization (red fitted curve,
Hodgkin-Huxley fit with slope 2, krec = 10 s
1) about 4-fold slower than wild-
type GluA2 (blue dashed line, 46 s1, Hodgkin-Huxley function with slope 2).
The upper trace indicates the timing of the pulses of 10 mM glutamate.
(B) The GluA2 Y768R mutation slowed recovery about 3-fold and made the
recovery monoexponential (red fitted line, krec = 14 s
1). Wild-type GluA2
recovery (blue dashed line) is as in (A).
(C) Combining the single mutations E713T and Y768R had a supra-additive
slowing effect on recovery. Eight paired-pulse records are overlaid, illustrating
recovery from desensitization that was about 25-fold slower compared towild-
type GluA2 (blue dashed curve). In this patch, the rate of recovery was 1.1 s1
(single exponential function, red fitted line).
(D) The early phase of recovery for the double mutant on an expanded time-
scale (same traces as C). Asterisk indicates the response for the doublemutant
(4% of receptors active) at the same interval by which wild-type GluA2
receptors have fully recovered.
(E) Bar plot summarizing the effects of mutations on half-recovery time (t50).
Bars representing mutants with similar recovery behavior to wild-type recep-
tors are colored green. The K716N DP717 mutant did not give glutamate-
activated currents. Error bars indicate SDM.
(F) A surface plot of the glutamate-bound GluA2 ligand binding domain (PDB
code: 1FTJ). Carbon atoms of mutated residues that had only small effects are
shown as green spheres. E713 and Y768 are in orange. See also Figure S3 for
an sequence alignment of D2 residues and Figure S4 for evidence of ther-
modynamic coupling between E713 and Y768.
Figure 4. Deactivation and Recovery Rates Are Correlated
(A) Glutamate potency for the A2 E713T Y768R double mutant (ET/YR) was
intermediate to wild-type GluA2 and GluK2. The EC50 determined from peak
currents following a concentration jump (filled circles), was 230 ± 20 mM (n = 5).
A dashed line indicates the equivalent curve for wild-type GluK2 receptors,
and a dotted line that for wild-type GluA2. Error bars indicate SDM.
(B) Pre-equilibration with low concentrations of glutamate blocks activation
with IC50 = 9 ± 1 mM in wild-type GluA2 (open squares, dotted line, n = 3–11
patches per point). The IC50 for GluK2 is much less, 700 ± 80 nM (open circles,
dashed line, n = 3–8 patches per point). Glutamate is about 35-fold more
potent at blocking activation in the A2 E713T Y768R mutant (IC50 = 240 ±
30 nM, filled circles, solid line, n = 5–7 patches per point) than in wild-type A2.
(C) Mutants of GluA2 that slow recovery also slow the decay of the response to
a 1 ms pulse of 10 mM glutamate. Normalized current responses are overlaid
for GluA2 wild-type (dashed line), Y768R and E713T Y768R mutants. The
upper trace shows the open tip response. Monoexponential fits to the decays
are shown, kdeact = 456 s
1 for Y769R (open circles) and 204 s1 for E713T
Y768R (filled circles). The wild-type decay was 1,200 s1.
(D) A strong correlation (Pearson r= 0.82, 95%confidence interval 0.56 to 0.94)
between deactivation and recovery rates for the panel of GluA2 mutants
(circles) holds over more than 2 orders of magnitude of recovery rate.
Orthogonal distance regression fitted a line with slope 26 ± 3. There was no
correlation between the entry and exit rates for desensitization (diamonds,
slope 0.01 ± 0.1, r = 0.01, 95% confidence interval 0.5 to 0.5). Wild-type
values are indicated with filled symbols.
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850 Neuron 74, 845–857, June 7, 2012 ª2012 Elsevier Inc.potently, at about 1,000-fold lower concentration than the EC50
for activation (IC50 = 240 ± 30 nM; n = 5–7 patches). The GluA2
Y768R single mutant was also more potently inhibited by gluta-
mate than wild-type GluA2 (IC50 = 3 ± 0.3 mM, data not shown).
These data demonstrate that the GluA2 TR mutant and GluK2
bind glutamate much more tightly in the desensitized state
than wild-type GluA2 does.
Fast Recovery Is Correlated with Fast Deactivation
For our panel of GluA2 mutants, we also measured the rate of
deactivation following a 1 ms pulse of saturating glutamate.
This experiment approximates synaptic transmission, where
Figure 5. Channel Openings Have Longer Duration in the A2 TR
Mutant
(A) Six consecutive records are shown for GluA2 wild-type (left panel) and the
A2 TR mutant (right panel) at –80mV. The white bars indicate glutamate
application. Black bars indicate sections plotted in panel (B). The asterisk
indicates a trace where the piezo stack was actuated but the pipette did not
enter glutamate solution. We discarded patches that showed activation from
endogenous channels in this condition.
(B) Magnified sections from the traces in (A). In the record corresponding to the
TR mutant, some examples of longer open periods can be discerned.
(C) The distributions of open periods (left panel) and shut times (right panel are
overlaid for wild-type (black) and A2 TR (gray). See also Figure S5 for 2D
histograms of open time against amplitude.
(D) Dot plot showing the mean open period for each patch. Lines indicate the
average.
(E) Dot plot of mean conductance weighted by occupancy for each patch.
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1992). Slow-recovering receptors (for example, the GluA2 TR
double mutant) had slower deactivation decays than wild-type
GluA2 (Figure 4C and Table 1). We plotted the deactivation
rate and the desensitization rate of each mutant against the
recovery rate (Figure 4D). Strikingly, the deactivation rate and
the recovery rate were strongly correlated (Pearson r = 0.82).
The correlation also held for mutants where recovery was
faster than wild-type channels, which tended to have faster
deactivation. There was little correlation between the rate of
recovery and rate of entry to desensitization (Pearson r = 0.01),
which varied less than 2-fold across the entire panel (range
89–159 s1, Table 1 and Table S1).
Open Periods Are Extended in the TR Mutant
The correlation between deactivation and recovery rates,
accompanied bymodest changes in glutamate apparent affinity,
suggests that mutations in D2 might alter activation gating, in
particular by lengthening apparent openings. We investigated
this hypothesis by recording the activations of individual wild-
type and A2 TR channels in 10 mM glutamate (Figure 5A).
Long (8 s) applications of 10 mM glutamate to patches contain-
ing 5–100 channels produced an initial peak response, followed
by well-spaced activations with two or three subconductance
levels (Figure 5B), and a rare full conductance level, as previously
reported (Zhang et al., 2008). The mean gap between activations
of a single channel (corrected for the number of channels, as
estimated from the peak response) was about 500 ms for WT
(n = 4 patches) and about 2,500 ms for TR (n = 4). Channels
were saturated with glutamate during these intervals, and so
these gaps cannot be compared to the rate of recovery from
desensitization, which occurs in the absence of glutamate.
Nonetheless, the longer gaps exhibited by the TR mutant are
consistent with a more stable desensitized state.
The distributions of open periods, which were well fitted with
double exponential densities (Figure 5C), suggested that
many openings were too brief to be detected. Apparent open-
ings are extended by missed shuttings, but this effect should
be similar for both A2 wild-type and the TR mutant because
of the similarity in their shut time distributions (Figure 5C).
With this caveat in mind, we detected a highly significant 2-
fold increase in the mean open period in the A2 TR mutant
(from 900 ± 100 ms to 1,900 ± 200 ms; p = 0.0028, n = 4 patches
for each mutant, Figure 5D). The time constant of the slower
component of the distribution increased from 1.8 ms (55% of
open periods on average, n = 4 patches) to 4.3 ms (41% of
open periods). No exact missed event correction is available
for data containing sublevels, so we cannot perform maximum
likelihood fitting (Colquhoun et al., 2003) to interpret the pro-
longed openings in terms of mechanisms. 2-D plots of ampli-
tude against open period revealed no correlation between
these two properties for wild-type or mutant receptors (Fig-
ure S5), suggesting that no specific sublevel is associated
with altered gating. Consistent with this idea, the mean
conductance, weighted by occupancy, for the A2 TR mutant
(Figure 5E; 19 ± 1 pS; n = 4 patches) was indistinguishable
from wild-type GluA2 (18 ± 1 pS; n = 4). The mean burst length
during applications of 10 mM glutamate was 8 ± 2 ms (that is,Neuron 74, 845–857, June 7, 2012 ª2012 Elsevier Inc. 851
Figure 6. Residues in D2 Also Combine to Control
Kainate Receptor Gating and Desensitization
(A) Bar plot summarizing the half recovery times for D2
mutants in GluK2 on a log scale. All mutants were best fit
with single exponential recovery functions. The five posi-
tions mutated in double, triple, and quadruple mutants are
E650, S679, M706, T715, and R769, respectively. Error
bars indicate SDM.
(B) Spatial distribution of the ARLE residues (green
spheres) in the GluK2 glutamate bound LBD- PDB code
3G3F. A dashed segment indicates a disordered stretch at
the C terminus of S2. The site of the GT linker is shown as
two black spheres. The bound glutamate is shown as
spheres.
(C) Recovery traces from the best recording of the ARLE
quadruplemutant are overlaid. Recovery is20-fold faster
than wild-type GluK2 (red curve). The upper traces show
the piezo command voltages.
(D) Recovery for GluK2 ARLE was best fit with a single
exponential function (8.6 ± 0.6 s1, n = 6 patches). Dotted
line shows the recovery of wild-type GluK2 and dashed
line that of GluA2.
(E) Mutants of GluK2 that speed recovery also speed the
decay of the response to a 1ms pulse of 10mMglutamate.
Normalized current responses are overlaid for GluK2
(dashed line), LEY (orange fitted curve; kdeact = 810 s
1)
and ARLE (green fitted curve; kdeact = 1,440 s
1).
(F) Deactivation and recovery rates for the panel of GluK2
mutants are correlated (diamonds; Pearson r = 0.64; 95%
confidence interval 0.23 to 0.86). Orthogonal distance
regression fitted a line with slope 490 ± 20. There was little
correlation between the entry and exit rates for desensiti-
zation (diamonds, slope 16 ± 3, r = –0.01, 95% confidence
interval 0.48 to 0.47). Wild-type GluK2 points are indi-
cated with filled symbols.
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(110 ± 20 s1) for TR. If we assume that almost all bursts were
terminated by desensitization, the inverses of these burst
lengths correspond well to the desensitization time constants
(see Table 1).
Domain 2 Also Controls Recovery and Decay Times in
Kainate Receptors
Previously published work established that individual sub-
stitutions in the D2 domain of GluK2 fail to alter the entry rate
for desensitization, and at most provide 5-fold speeding of852 Neuron 74, 845–857, June 7, 2012 ª2012 Elsevier Inc.recovery (Fleck et al., 2003). The strong effect
of the TR mutant on AMPA receptor recovery
guided us to examine the substitutions T715E
and R769Y in GluK2 (equivalent to E713T and
Y768R in GluA2). However, individual mutations
at this site alone gave at best minor speeding
of recovery (Table 1), and the tandem exchange
slowed recovery. In GluK2 (PDB: 3G3F
(Chaudhry et al., 2009a)), helix I and helix K
approach closer than in GluA2, with T715 and
R769 pointing in opposite directions, possibly
explaining the limited effect. Instead, combining
mutants distributed across the lower lobe ofthe GluK2 LBD (see Figures 6A and 6B) was much more effica-
cious. As in the case of the triple DTR mutant in GluA2, the
cumulative effect of combining mutations was to reduce the
amplitude of membrane currents and we obtained numerous
‘‘blank’’ patches for triple mutants. Of the two quadruple mutant
combinations we made, one was nonfunctional (GluK2 D656A
S675RM706L T715E) and the other typically gave patch currents
in the 10 pA range. This quadruple mutant (GluK2 E650A S675R
M706L T715E; ARLE) recovered about 20-fold faster than wild-
type GluK2 (Figures 6C and 6D; 8.6 ± 0.7 s1, n = 6 patches),
with a halftime of recovery (t50) of 80 ms, only about 3-fold longer
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tions (e.g., GluK2 L511M Y512I E650A S675R M706L T715E)
also failed to give expression of membrane currents.
We were not able to measure glutamate apparent affinity for
the quadruple ARLE mutant because currents were small and
exhibited strong rundown. The triple S675R M706L T715E
mutant (GluK2 RLE) had glutamate potency slightly lower than
that at wild-type GluA2 (EC50 = 2.8 ± 0.1 mM, n = 5 patches).
The potency of glutamate at the M706L single mutant was indis-
tinguishable (EC50 = 3.1 ± 0.3 mM, n = 10 patches), even though
the RLE mutant recovers about twice as fast as M706L alone
(Table 1). Notably, a similar 20-fold shift in potency due to point
mutations in the jaws of GluK2 (Weston et al., 2006b) such as
K456A, only speeds recovery 4-fold (compared to the more
than 10-fold speeding for GluK2 RLE).
Mutations that sped K2 recovery also sped up the deacti-
vation decay (Figure 6E), mirroring the situation in AMPA
receptors, and we obtained a similar correlation across the
mutant series (Figure 6F, Pearson r = 0.64 for the correlation
between krec and kdeact). Only one mutation (GluK2 L511M
Y512I) altered the desensitization rate outside a 2-fold range
across the entire series, closely matching the situation in
AMPA receptors (Table S1; Pearson r = –0.01 for the correlation
between krec and kdes).
A Simple Activation Mechanism that Accounts
for the Observed Correlations
A positive correlation between recovery and deactivation rates is
expected if glutamate affinity changes for all states. Such
a change should also strongly alter glutamate potency for
channel activation, a phenomenon that we detected only in
GluK2 constructs harboring the M706L mutation. The behavior
of other mutants, such as A2 TR, for which deactivation decays
and recovery both changed with only limited shifts in EC50, are
not predicted by the mechanism in Figure 2A (data not shown).
We reasoned that the correlation could be recapitulated by link-
ing the open state to the deep desensitized state. Schemes with
long lived desensitized states connected to open states were
previously proposed to describe the activation of native gluta-
mate receptors (Ha¨usser and Roth, 1997; Jonas et al., 1993).
However, in other studies, desensitization was taken to proceed
only from shut states (Vyklicky et al., 1991; Robert and Howe,
2003) or from either shut or open states (Lin and Stevens,
1994; Raman and Trussell, 1995), and the concept of desensiti-
zation from open states has remained controversial (Colquhoun
and Hawkes, 1995a). Because connecting these two states
forms a reversible loop, changes in the rate d2– must be
compensated by changes in another rate constant to ensure
microscopic reversibility is obeyed (Colquhoun et al., 2004).
We performed extensive trial simulations (data not shown) allow-
ing various rate constants on the loop to covary with d2– (see
Figure 7A). A tolerable representation of the observed kinetic
behavior of our mutant panel was only obtained if the rate of
channel closure (a) was varied with d2–. This regime allowed
shifts in the recovery rate of more than 2 orders of magnitude
(Figure 7B). The deactivation rate was altered in the same range
as our mutant series (Figure 7C). Slower rates of channel closure
for slower recovering channels also predict longer individualchannel openings, as we observed for the A2 TRmutant. Despite
the range of efficacies (b/a) being greater than 1,000-fold, the
model predicted only limited effects on the peak open probability
and extent of steady-state desensitization (because these
properties are principally determined by the ratios b / d1+ and
d2*+ / d2*, respectively). At slow recovery rates, the foot of
the concentration response relation was distorted (Figure 7E),
but the shifts in glutamate potency were modest, as for the A2
TRmutant (Figure 4A). Predicted recovery and deactivation rates
were positively correlated, and approximately fit by a power law
relation, with exponent about 1.5 (Figure 7G). As in our mutant
series, the predicted desensitization rate was barely altered
across the entire range of recovery rates. We investigated if
our original model (Figure 2A) could describe the observed
data, if both a and d2– were varied without a connection
between the desensitized and open states, but rate of entry to
desensitization varied strongly with recovery rate in this case
(data not shown), in direct opposition to our observations
(Figures 4D and 6F). The deviation from the linear correlation
observed in the mutant panel may be due to the oversimplifica-
tion of our model, relative to the true activation mechanism, and
is one indication that further work to refine these activation
mechanisms is necessary. Nonetheless, this simple reaction
scheme shows that covariation of open and desensitized state
lifetimes, due to reversibility constraints or other mechanisms,
can lead to the correlations that we observed for our mutant
series.
DISCUSSION
Our chimeras and mutant screens demonstrate that domain 2 of
the AMPA and kainate receptor ligand binding domains
determine both the lifetime of the desensitized state and the
deactivation decay. These surprising results augment the estab-
lished idea that the chemistry and dynamics of the ligand binding
domains are central in determining glutamate receptor kinetic
behavior. Our results exclude agonist potency as the basis of
the difference in recovery rate between wild-type receptors.
Consistent with this observation, none of the mutations that shift
recovery contribute directly to the glutamate-binding pocket.
Instead, our kinetic simulations predict that the most plausible
explanation for our observations is the existence of a deep de-
sensitized state in kainate receptors that is much less stable in
AMPA receptors. Similar desensitized states, from which
unbinding of glutamate should be slow, have been proposed
before for AMPA receptors (Robert and Howe, 2003). This
suggests a state where the closure of the ligand binding clam-
shells is stabilized by interactions that allow glutamate to stay
trapped when the channel is closed.
Entry to desensitization occurs by the common mechanism of
D1 dissociation in AMPA and kainate receptors (Chaudhry et al.,
2009a; Sun et al., 2002), and is controlled by subunit interfaces
between domains 1. In contrast, we show that sites in D2
alter recovery profoundly, but are unlikely to mediate direct
interactions between subunits. For example, destabilization of
desensitized dimers in GluA2 by E713, through electrostatic
repulsion or steric hindrance, which could be relieved by the
E713T mutation, is implausible, because the C-alphas of E713Neuron 74, 845–857, June 7, 2012 ª2012 Elsevier Inc. 853
Figure 7. A Simple Mechanism Can Account for
the Observed Kinetic Correlations
(A) The modified activation mechanism permits the
receptor to transition to the deep desensitized state
directly from the open state. Values of the rate constants
(per second) were as follows: b = 4,000, d2+ = 150, d2*+ =
150, d2* = 10, k+ = kd+ = 1$107 M1, k– = 20,000, kd– =
1500, d1+ = 600, d1– = 100, d0+ = 4, d0– = 9. In the
simulations shown, the channel closing rate (a, green
arrow; range 5.3 to 3,349 s1) was covaried with d2– (red
arrow; range 0.05 to 79 s1) to ensure microscopic
reversibility was obeyed on the loop.
(B) A uniform shift in recovery rate of more than two orders
of magnitude results from changes in d2–. In each panel,
traces are colored according to values of d2– in the upper
panel.
(C) The relaxation at zero glutamate following population
of the open state is faster at higher values of d2– (and
therefore higher values of a).
(D) The response to a long pulse of 10 mM glutamate is
similar for all values of d2–. Low values of d2– and a ten-
ded to reduce the peak and steady-state current.
(E) The peak-current concentration relation (normalized
to the maximum open probability) is distorted at low
concentrations, but glutamate potency shifted only about
7-fold over the entire range of variation in d2– (EC50 range:
130–880 mM). Inset shows the same relation without
normalization.
(F) Summary plot of the change in deactivation rate,
recovery rate and EC50 with d2–. Coloring corresponds to
that in (B).
(G) Values of krec and kdeact derived from simulated
currents were strongly positively correlated (open circles)
and approximately fit by a power law relation (dotted line,
exponent 1.5). The desensitization rate (kdes, filled circles)
did not change with krec. Empirically determined values
from WT A2 (open diamond), A2 TR (triangle) and A2 DTR
(square) are indicated.
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dimer (Armstrong et al., 2006). The chimeras we used in this
study include part of the pre-M4 linker, but it is unlikely that
this segment has an influence on recovery. Chimeras with
a boundary N-terminal to this linker, at a conserved double
tryptophan motif (WW; Figure S6), although largely retained
in the endoplasmic reticulum, had indistinguishable recovery
characteristics to the chimeras we used.
Although the active dimers of LBDs are likely to be the same in
AMPA and kainate receptors (Weston et al., 2006a), a full-length
structure placing these dimers in context is available only for
GluA2 bound with antagonist (Sobolevsky et al., 2009). The
organization of the four LBDs in the desensitized state might
differ between receptor classes, allowing for differences in854 Neuron 74, 845–857, June 7, 2012 ª2012 Elsevier Inc.stability, but several of our observations
suggest that any interdimer interactions are
limited. Although engineered interdimer disul-
fide bonds crosslink sites in helices G and K in
GluK2 (Das et al., 2010), the adjacent S679R
mutation in helix G of GluK2 was only effective
in speeding recovery as a member of a set of
exchanges. Further, the recovery of the GluK2N771K mutant, the equivalent crosslinking site in helix K, and
of GluA2 mutants harboring the reverse exchanges, were indis-
tinguishable from those of the respective wild-type receptors
(Table 1 and Table S1).
If direct intersubunit interactions are not responsible for the
shift in desensitization state lifetime, two other major possibilities
remain. First, domain 2 could adopt multiple orientations relative
to domain 1 during desensitization, perhaps corresponding to
the different distances discerned in single molecule FRET
studies, which are otherwise too slow to be involved in gating
(Landes et al., 2011). These orientations could differ between
AMPA and kainate receptors. Second, domain 2 might deform
between different functional states rather than translating
purely as a rigid body during gating motions. Distributed
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Glutamate Receptor Desensitization and Gatingmutations could alter the balance between different conforma-
tions to alter recovery. In NMDA receptors, the redox state of
the disulfide bond at the base of domain 2 might alter receptor
activity by allowing deformation of D2 (Choi et al., 2001). NMR
studies revealed that the beta core of domain 2 in GluA2 is the
most mobile part of the LBD (McFeeters and Oswald, 2002).
Ligand selective chemical shifts are also detected for the region
around the conserved disulfide bond (abutted by Glu 713 in
GluA2) and helix I (Valentine and Palmer, 2005). Domain 2
exhibits ligand-specific conformations in GluN2D subunits
(Vance et al., 2011), and domain 2 generally has higher crystallo-
graphic temperature factors than domain 1, but detecting
conformational plasticity through crystallographic studies at
the relevant sites might be challenging. In GluA2, Tyr 768 lies
at the C terminus of the soluble LBD, which is often engineered
to permit crystallization (Mayer et al., 2006), and is also often
disordered. Molecular dynamics simulations and NMR studies
may provide insights into how D2 dynamics control glutamate
receptor gating.
We have obtained a double-mutant AMPA receptor with very
slow recovery, which may find application as a tool to study
desensitization in native cells. In contrast, serial exchanges
were necessary to obtain fast recovering kainate receptors.
Could fast recovery be an essential adaptation in AMPA recep-
tors that required extensive tuning, and which can be ‘‘broken’’
comparatively easily? Collecting sufficient data to examine this
idea properly seems impractical, because quaternary (and
higher order) combinations of mutations in GluK2 express so
poorly. We know that complete exchange of the intact ligand
binding domains swaps both recovery and deactivation kinetics
between AMPA and kainate receptors. In this case, the swapped
LBDs contain all necessary nonconserved variations to confer
functional differences, but presumably also harbor coevolved
second-site suppressors to maintain efficient folding, stability,
and maturation, which perhaps our point mutants lack.
The observed correlation between deactivation rate (kdeact)
and recovery from desensitization (krec) has implications for the
activation mechanisms of AMPA and kainate receptors. These
coupled kinetic properties are tuned during brain development
through changes in subunit composition at synapses. One
example is in neurons of the auditory pathway, where AMPA
receptor EPSCs are accelerated at hearing onset, as GluA1-
containing receptors are replaced by those incorporating
the faster recovering GluA4 subunit (Joshi et al., 2004; Taschen-
berger and von Gersdorff, 2000). Recapitulation of the correla-
tion by a simple mechanism in which the open state and the
desensitized state are connected suggests the possibility that
the same molecular interactions that slow recovery also slow
channel closure. Because the structures of the open and deep
desensitized states are likely to differ appreciably, the connec-
tion between open and desensitized states may consist of
multiple transitions. Such a correlation could also result without
desensitization from the open state, but other features of our
data are not described in this case. Simple changes in affinity
do not predict the existence of mutants (or wild-type receptors)
where apparent affinities do not differ much but which have
dramatically different recovery. In NMDA and GABA receptors,
agonist unbinding is slow. Thus long shut sojourns (which mayinvolve desensitized states) contribute considerably to the
synaptic decay for both receptor classes. Reopening of NMDA
and GABA receptors following a long shut state occurs because
the channel opening rate is similar to the unbinding rate (Jones
and Westbrook, 1995; Popescu et al., 2004). If AMPA channels
are functioning in a similar way, only accelerated about 100-
fold, faster recovery of receptors from the desensitized state
and speeding of channel closure might be a way of sharpening
the synaptic current and limiting noise by minimizing reopening,
as well as ensuring maximum availability of receptors over a
wide input bandwidth.EXPERIMENTAL PROCEDURES
Molecular Biology
To construct S1S2 chimeras, we amplified inserts containing the GluA2 or
GluK2 ligand binding domains with splice sites to the parent backbone via
overlap PCR. Domain boundaries, which were sequence neutral, were as
follows: B2P6 – K2 (T1-N399) A2 (N382-P507) K2 (P513-S635) A2 (S631-
K781) K2 (K779-A877); B6P2: A2 (V1-N382) K2 (N399- P513) A2 (P507-
S631) K2 (S635-K779) A2 (K781-I862). Point mutations were introduced by
overlap PCR and confirmed by double-stranded sequencing. Numbering
refers to the mature polypeptide chain.
Cell Culture and Electrophysiology
Wild-type and mutant glutamate receptors were overexpressed in HEK293
cells as described (Chen et al., 1999). For most experiments, the external
solution contained (in mM): 150 NaCl, 0.1 MgCl2, 0.1 CaCl2, and 5 HEPES,
titrated to pH 7.3 with NaOH, to which we added drugs as required. In exper-
iments to assess the ion sensitivity of chimeras, we replaced NaCl with NaNO3
or CsCl. Drugs were obtained from Ascent Scientific (Weston-Super-Mare,
UK). The pipette solution contained (in mM): 115 NaCl, 10 NaF, 0.5 CaCl2,
1 MgCl2, 5 Na4BAPTA, 5 HEPES and 10 Na2ATP (pH 7.3). We applied ligands
to outside out patches via a piezo driven fast perfusion system. Typical
10%–90% solution exchange times were faster than 300 ms, as measured
from junction potentials at the open tip of the patch pipette. For single-channel
recording, outside-out patches were clamped at –80mV during long applica-
tions (8 s) of 10 mM glutamate. Records were filtered at 1–2 kHz and idealized
using time course fitting (SCAN, available from onemol.org.uk).
Data Analysis
To measure recovery from desensitization, we used a two-pulse protocol
with a variable interpulse interval. Recovery data were fitted by a Hodgkin-
Huxley-type function:
N=N0 + ð1 N0Þ$ð1 expð  krectÞÞn
where N is the active fraction of receptors at time t following the first pulse, N0
was the active fraction at the end of the conditioning pulse, and krec was the
rate of recovery. Concentration-peak current data were fitted with Langmuir
single binding isotherms:
IðxÞ= Imax$ ½x½x+EC50
where I(x) was the response at glutamate concentration, x; Imax the maximum
response; and EC50 the concentration of half-maximal activation. For
measurements of equilibrium desensitization, we bathed the patch in low
concentrations of glutamate via the control barrel. Residual responses to
10 mM glutamate were fitted with the following equation:
IðxÞ= Imax$ IC50½x+ IC50
where I(x) was the response following preincubation at a given concentration of
glutamate, x; Imax was themaximum response; and IC50 was the concentration
of half-maximal inhibition.Neuron 74, 845–857, June 7, 2012 ª2012 Elsevier Inc. 855
Neuron
Glutamate Receptor Desensitization and GatingKinetic Modeling
We calculated the relaxations for simplified activation mechanisms, in line
with previously published work (Robert et al., 2005). For each simulation,
the mechanism was encoded by a Q-matrix, microscopic reversibility was
imposed on any cycles (Colquhoun et al., 2004) and relaxations were
calculated using standard methods (Colquhoun and Hawkes, 1995b). We
then calculated the occupancy of the various states in the model during
relaxations (P(t)) according to the following equation (Colquhoun and Hawkes,
1977):
PðtÞ=P0$exp½Qt
P0 is the initial occupancy of the states in the mechanism. Further informa-
tion is found in the Supplemental Experimental Procedures.
Figures were prepared with Kaleidagraph (Synergy Software), Igor Pro
(Wavemetrics), and Pymol. Results are reported as the mean ± SD of the
mean, and significance was assessed with Student’s t test (two-tailed
distribution).SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.neuron.2012.04.020.ACKNOWLEDGMENTS
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